Dong-A ST Co Ltd banner
D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 57 200 KRW -1.04% Market Closed
Market Cap: ₩534.8B

Net Margin

-0.3%
Current
Declining
by 0.3%
vs 3-y average of 0%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-0.3%
=
Net Income
₩-2.2B
/
Revenue
₩770.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-0.3%
=
Net Income
₩-2.2B
/
Revenue
₩770.6B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Dong-A ST Co Ltd
KRX:170900
523.9B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
989.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
573.4B USD
Loading...
CH
Roche Holding AG
SIX:ROG
281.1B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
302.9B USD
Loading...
CH
Novartis AG
SIX:NOVN
230.9B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.1B GBP
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
154B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.3B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
37th
Based on 2 632 companies
37th percentile
-0.3%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Dong-A ST Co Ltd
Glance View

Market Cap
534.8B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
70 000.57 KRW
Undervaluation 18%
Intrinsic Value
Price
D
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-0.3%
=
Net Income
₩-2.2B
/
Revenue
₩770.6B
What is Dong-A ST Co Ltd's current Net Margin?

The current Net Margin for Dong-A ST Co Ltd is -0.3%, which is below its 3-year median of 0%.

How has Net Margin changed over time?

Over the last 3 years, Dong-A ST Co Ltd’s Net Margin has decreased from 3.2% to -0.3%. During this period, it reached a low of -3.5% on Sep 30, 2024 and a high of 3.2% on Aug 30, 2022.

Back to Top